[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100500421":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":10,"locations":10,"responsibleParty":16,"collaborators":10,"id":18,"slug":19,"hasResults":20,"nctId":21,"briefTitle":22,"officialTitle":22,"acronym":10,"eligibilityCriteria":23,"healthyVolunteers":20,"sex":24,"minAge":25,"maxAge":10,"enrollmentInfo":26,"targetDuration":10,"studyType":29,"phases":10,"briefSummary":30,"conditions":31,"keywords":10,"overallStatus":38,"whyStopped":10,"lastUpdateSubmitDate":39,"lastUpdatePostDateStruct":40,"startDateStruct":43,"completionDateStruct":45,"leadSponsor":47,"locationsCount":10},{"fullName":5,"class":6},"Target PharmaSolutions, Inc.","INDUSTRY",[8,12,14],{"label":9,"type":10,"description":11,"interventionNames":10},"Disease Cohort",null,"Observational",{"label":13,"type":10,"description":11,"interventionNames":10},"Engaged Cohort",{"label":15,"type":10,"description":11,"interventionNames":10},"Age Cohort",{"type":17,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100500421","an-observational-study-of-patients-living-with-chronic-neurological-diseases-100500421",false,"NCT05796037","An Observational Study of Patients Living With Chronic Neurological Diseases","Disease Cohort\n\nInclusion Criteria:\n\n•Adult patients at the time of enrollment with a diagnosis of ADRD, MCI, PD, or MS by select ICD-10 codes in the EHR interface\n\nExclusion Criteria:\n\n* Death\n* Manual removal (sponsor or site request)\n* No EHR interface encounter \\> 3 years\n\nEngaged Cohort\n\nInclusion Criteria:\n\n* Adult patients diagnosed and managed for these conditions invited to participate\n* Ability to provide written informed consent (or have a legally authorized representative to provide informed consent)\n* Care partners may be invited to participate in surveys and will provide informed consent.\n\nExclusion Criteria:\n\n* Patient expressed desire to withdraw consent to complete PROs\n* Care partner expressed desire to withdraw consent to complete PROs\n* Failure to complete PROs within 24 weeks of initial invitation\n* Greater than 24 months lapse of survey completion after baseline surveys completed\n* Additionally, the criteria detailed for Disease Cohort apply to the Engaged Cohort\n\nAge Cohort\n\nInclusion Criteria:\n\n•Adult patients aged 60 and older at time of enrollment\n\nExclusion Criteria:\n\n* Death\n* Manual removal (sponsor or site request)\n* No EHR interface encounter \\> 3 years","ALL","18 Years",{"count":27,"type":28},1500000,"ESTIMATED","OBSERVATIONAL","TARGET-NEURO is an observational research study to conduct a comprehensive review of outcomes for patients living with chronic neurological diseases: Alzheimer's disease and related dementia (ADRD), mild cognitive impairment (MCI), Parkinson's disease (PD), and multiple sclerosis (MS).",[32,33,34,35,36,37],"Neurological Diseases or Conditions","Dementia of Alzheimer Type","Alzheimer Disease","Mild Cognitive Impairment","Parkinson Disease","Multiple Sclerosis","NOT_YET_RECRUITING","2024-11-18",{"date":41,"type":42},"2024-11-20","ACTUAL",{"date":44,"type":28},"2025-03-31",{"date":46,"type":28},"2038-12-31",{"name":5,"class":6}]